Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Euclidean Capital LLC (CIK 1825034) reported $392.3M across 10 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: VEU ($243.6M, 62.09%), VTV ($102.0M, 26.01%), INDA ($17.3M, 4.41%), ORIC ($12.5M, 3.20%), FHTX ($7.5M, 1.92%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | VEU | VANGUARD INTL EQUITY INDEX F | $243.6M | 62.09% | 3.2M | Added |
| 2 | VTV | VANGUARD INDEX FDS | $102.0M | 26.01% | 520,000 | Hold |
| 3 | INDA | ISHARES TR | $17.3M | 4.41% | 369,600 | Hold |
| 4 | ORIC | ORIC PHARMACEUTICALS INC | $12.5M | 3.20% | 989,410 | Hold |
| 5 | FHTX | FOGHORN THERAPEUTICS INC | $7.5M | 1.92% | 1.6M | Hold |
| 6 | PMVP | PMV PHARMACEUTICALS INC | $3.3M | 0.83% | 2.6M | Hold |
| 7 | ALEC | ALECTOR INC | $2.8M | 0.72% | 1.3M | Hold |
| 8 | SRZN | SURROZEN INC | $2.6M | 0.65% | 87,696 | Hold |
| 9 | TNYA | TENAYA THERAPEUTICS INC | $703,274 | 0.18% | 1.0M | Hold |
| 10 | RAPT | RAPT THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 11 | SPY | SPDR S&P 500 ETF TR | $0 | 0.00% | 0 | Exited |
| 12 | SRZNW | SURROZEN INC | $2,733 | 0.00% | 170,833 | Hold |
Source: SEC Form 13F filings · as of 2026-03-31